Neither approach helps you make an actual decision
[DOI] [PMC free article] [PubMed] [Google Scholar] 91.Schain A., Melo-Carrillo A., Strassman A., Burstein R
Research reading: This compound is part of our Peptides research category, which includes a range of laboratory-grade peptide compounds studied in controlled environments
Interest in this next-generation compound has surged thanks to its unique triple-agonist mechanism and impressive clinical trial results
While the FDAs Food, Drug, and Cosmetic Act allows it to turn a blind eye to pharmacists producing and selling non-approved compounded versions under certain circumstances, this practice has led to a billion-dollar shadow industry of compounded GLP-1 drugs
Archived from the original on 4 January 2024